Owner Institute of Medicinal Molecular Design, Inc.

Inventors Muto, Susumu; Itai, Akiko

Agent Collison & Co

Pub. Number AU-B-2003242108

PCT Number PCT/JP03/07121

PCT Pub. Number WO2003/103655

Priority 2002-168332 10.06.02 JP

Filing date 5 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 11 September 2008

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/255 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/437 (2006.01)

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/47 (2006.01) - Quinolines

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/616 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents